At a glance
- Originator sigma-tau SpA
- Class Antihypertensives
- Mechanism of Action Dopamine receptor agonists; Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Immunological disorders
Most Recent Events
- 15 Dec 1995 New profile for Immunological Disorders.
- 15 Dec 1995 Discontinued-Preclinical for Immunological disorders in Italy (Unknown route)